LIPIDSEQ Trademark

Trademark Overview

On Thursday, August 18, 2022, a trademark application was filed for LIPIDSEQ with the United States Patent and Trademark Office. The USPTO has given the LIPIDSEQ trademark a serial number of 97553758. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Boston Heart Diagnostics Corporation. The LIPIDSEQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes
lipidseq

General Information

Serial Number97553758
Word MarkLIPIDSEQ
Filing DateThursday, August 18, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7175340
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code044
First Use Anywhere DateFriday, July 29, 2022
First Use In Commerce DateFriday, July 29, 2022

Trademark Owner History

Party NameBoston Heart Diagnostics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702
Party NameBoston Heart Diagnostics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702
Party NameBoston Heart Diagnostics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702

Trademark Events

Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 22, 2022NEW APPLICATION ENTERED

Related Keywords

lipidseq purposes treatment diagnostic testing medical